These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23570589)

  • 1. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
    Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular risk factors and cognitive impairment of patients with magnetic resonance imaging-defined subcortical ischemic depression].
    Long Y; Yang TT; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(5):307-11. PubMed ID: 22490832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of brain atrophy on the cognition in patients with subcortical ischemic vascular disease].
    Tong XX; Wang L; Zhou X; Zhang C; Fang L; Zhou YJ; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(1):14-9. PubMed ID: 26792601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlates of cognitive impairment in patients with leukoaraiosis by magnetic resonance spectroscopy].
    Yuan JL; Wang SK; Guo XJ; Peng P; Gu H; Zhao WH; Niu SQ; Hu WL
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(5):303-6. PubMed ID: 22490831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of cognitive functions and neuropsychiatric symptoms between patients with Parkinson's disease dementia and Alzheimer's disease].
    Tang Y; Ji XJ; Xing Y; Zuo XM; Zhou AH; Jia JP
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2459-62. PubMed ID: 24300264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal assessment battery in patients with Parkinson disease in a Turkish population.
    Kenangil G; Orken DN; Ur E; Forta H
    Cogn Behav Neurol; 2010 Mar; 23(1):26-8. PubMed ID: 20299860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and cognitive impairment in patients with mild parkinsonian signs.
    Uemura Y; Wada-Isoe K; Nakashita S; Nakashima K
    Acta Neurol Scand; 2013 Sep; 128(3):153-9. PubMed ID: 23397887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
    Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between vascular stenosis and cognition in leukoaraiosis patients].
    Zhang C; Zhou X; Wang L; Liu H; Zhu M; Sun Z
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(1):44-7. PubMed ID: 25876809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep].
    Gong Y; Xiong KP; Mao CJ; Huang JY; Hu WD; Han F; Chen R; Liu CF
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2637-41. PubMed ID: 24360043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.
    Saka E; Elibol B
    Parkinsonism Relat Disord; 2009 Nov; 15(9):688-91. PubMed ID: 19446489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of cognitive impairment in patients with leukoaraiosis].
    Yuan JL; Wang SK; Peng P; Guo XJ; Gu H; Li SJ; Qin W; Hu WL
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(3):147-51. PubMed ID: 22490733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.